BioSpace News Archive

Business

Immunovaccine and Leidos Expand Collaboration to Develop Malaria Vaccines Formulated in DepoVax

The two companies will expands its collaboration to develop preventative, peptide-based malaria vaccine candidates.

November 21, 2017

·

5 min read

AC Immune to Host Key Opinion Leader Meeting on Tau as a Therapeutic and Diagnostic Target in Alzheimer’s and other Neurodegenerative Diseases

The event will be held on December 1, 2017 from 12.00pm - 1.45pm ET at the St. Regis Hotel, 2 E. 55th Street in New York, NY.

November 21, 2017

·

6 min read

Drug Development

New Data from Zogenix’s Phase III Trial of ZX008 in Dravet Syndrome (Study 1) and Findings on Disease Impact to be Presented at 71st American Epilepsy Society Annual Meeting

These posters will be presented at the 71st American Epilepsy Society (AES) Annual Meeting, which will take place at the Washington Convention Center in Washington, D.C., from December 1-5, 2017.

November 21, 2017

·

6 min read

Policy

Novelion Therapeutics Provides Update on Agreement Between Aegerion Pharmaceuticals and U.S. Department of Justice

The Company, in consultation with its outside counsel, is currently evaluating its options and next steps.

November 21, 2017

·

1 min read

FDA

Teligent Announces FDA Approval of Erythromycin Topical Solution USP, 2%

This is Teligent’s eighth approval for 2017.

November 21, 2017

·

2 min read

Pharm Country

AIT Therapeutics to Hold Clinical Update Meeting on November 28, 2017 at 7:30 a.m.

Will present data from its NO-NTM Phase 2 clinical trial for patients suffering from Nontuberculous Mycobacteria (NTM) Abscessus.

November 21, 2017

·

3 min read

Business

Auris Medical to Report Third Quarter 2017 Financial Results and Provide Business Update on Tuesday, November 28, 2017

Following the announcement, Auris Medical’s management team will host a live conference call and webcast at 8:00 am Eastern Time.

November 21, 2017

·

1 min read

Drug Development

Catalyst Pharmaceuticals Announces Phase II Study of Firdapse in Ambulatory Patients With Spinal Muscular Atrophy (SMA)

The study will be conducted by a team of researchers led by Lorenzo Maggi, MD, and Giovanni Baranello, MD, of the Fondazione Istituto Neurologico Carlo Besta in Milan, Italy, a major referral center for SMA patients.

November 21, 2017

·

7 min read

Drug Development

Ablynx: Results From the Phase III Hercules Study of Caplacizumab for the Treatment of Acquired TTP Selected For Presentation in the Late-Breaking Abstracts Session at the 2017 ASH Annual Meeting

Positive topline results from the Phase III HERCULES study, meeting primary and two key secondary endpoints, were announced on 2 October 2017.

November 21, 2017

·

5 min read

BioMidwest

DiaMedica Accelerates Warrant Expiry Date

Any warrants not exercised prior to the accelerated expiry date and time will expire without any further action being taken.

November 21, 2017

·

3 min read